Molly Henderson Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Molly Henderson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Molly Henderson. Molly Henderson is an Executive Vice President & CFO in Advaxis, Inc. ($ADXS) and a CFO in VirtualScopics, Inc. ($VSCP) and a CFO in Lion Biotechnologies, Inc. ($LBIO) and a Chief Financial Officer in Lion Biotechnologies, Inc. ($LBIO) and a Chief Financial Officer in UroGen Pharma Ltd. ($URGN).
Address: 350 LINDEN OAKS ROCHESTER US 14625 NY
Companies in which Molly Henderson is an Insider
Advaxis, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Molly Henderson: Executive Vice President & CFO
Holdings: 5,833 shares
Current Value: $53,372
Latest Transaction: May 05 2020
$ADXS Market Capitalization: $360.52M
$ADXS Previous Close: $9.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IOVANCE BIOTHERAPEUTICS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Molly Henderson: CFO, Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 15 2016
$IOVA Market Capitalization: $437.71M
$IOVA Previous Close: $7.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
UroGen Pharma Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Molly Henderson: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Feb 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VirtualScopics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Molly Henderson: CFO
Holdings: 6,440 shares
Latest Transaction: Mar 17 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Molly Henderson
Sentiment: All, ADXS, IOVA, URGN, VSCP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Henderson Molly | Chief Financial Off ... | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Henderson Molly | Chief Financial Off ... | Option Exercise | A | 22.07 | 6,000 | 132,420 | 6,000 | |
| May 05 2020 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Option Exercise | A | 0.66 | 50,000 | 33,000 | 50,000 | |
| Oct 25 2019 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Option Exercise | A | 0.31 | 25,000 | 7,750 | 25,000 | |
| Apr 11 2019 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Grant | A | 3.68 | 2,500 | 9,200 | 5,833 | 3.3 K to 5.8 K (+75.01 %) |
| Apr 10 2019 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Grant | A | 3.85 | 100 | 385 | 100 | 0 to 100 |
| Apr 10 2019 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Grant | A | 3.86 | 2,900 | 11,194 | 2,900 | 0 to 2.9 K |